Athanasios Papakostas, MD
Retina Specialist · Brentwood, MONPI 1588975346
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Alcon at 30.0% of the total. Reporting peaked in 2019 at $33,914 and has fallen 90.2% since, to $3,335 in 2025. Among retina specialist clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 173 payments — averaging $489.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$25K
- Alimera Sciences, Inc.$20K
- Genentech USA, Inc.$20K
- Eyepoint US, Inc.$4K
- Mallinckrodt Enterprises LLC$4K
- Bausch & Lomb Americas Inc.$3K
- plus $9K from 21 others
Across 11 payments — averaging $16,197 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Roche TCRC, Inc.$177K
- F. Hoffmann-la Roche AG$835
What the payments were for
- Consulting fees$49,80159%
- Speaking & faculty fees$16,96520%
- Travel & lodging$10,32612%
- Food & beverage$7,5409%
- Education$150%
- Gifts$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 22 | $25,402 |
| Alimera Sciences, Inc. | 30 | $20,390 |
| Genentech USA, Inc. | 35 | $19,639 |
| Eyepoint US, Inc. | 5 | $3,599 |
| Mallinckrodt Enterprises LLC | 2 | $3,500 |
| Bausch & Lomb Americas Inc. | 6 | $2,858 |
| Genentech, Inc. | 2 | $1,850 |
| Johnson & Johnson | 1 | $1,545 |
| Spark Therapeutics, Inc. | 1 | $828 |
| Alcon Research LLC | 1 | $700 |
| Regeneron Healthcare Solutions, Inc. | 17 | $686 |
| AbbVie(2 entities) | 21 | $578 |
| Thrombogenics, Inc. | 2 | $557 |
| Oculus Surgical Inc. | 2 | $510 |
| Vertex | 1 | $508 |
| Dutch Ophthalmic, USA | 3 | $447 |
| Biogen | 4 | $157 |
| Carl Zeiss Meditec USA, Inc. | 1 | $152 |
| Amgen | 2 | $141 |
| Rxsight Inc | 1 | $138 |
| Novartis | 2 | $118 |
| Astellas Pharma US Inc | 4 | $108 |
| Carl Zeiss Meditec, Inc. | 1 | $70 |
| Harrow Eye, LLC | 3 | $63 |
| Coherus Oncology, Inc. | 2 | $50 |
| Regeneron | 1 | $40 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iluvien$20,112
- Constellation$15,044
- Lucentis$12,268
- VABYSMO$8,608
- ARGOS$5,600
- ACTHAR$3,500
- YUTIQ$3,271
- EYP-1901$1,850
- Balversa$1,545
- STELLARIS$1,250
- VICTUS$1,250
- LUXTURNA$828
- Jetrea$500
- Luxor$290
- EVA, combined machine$279
- EVA Ophthalmic Surgical System$169
- NGENUITY$150
- LenSx$150
- TISSUEBLUE$145
- RXSIGHT CONTACT LENS$138
How this compares
$84,656 in reported general payments places this provider in the 90th percentile of 45 retina specialist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 245 | $8,609 |
| MoxifloxacinMoxifloxacin Hcl | 95 | $1,872 |
| Atropine Sulfate | 55 | $1,623 |
| Ketorolac Tromethamine | 81 | $1,549 |
| Brimonidine Tartrate | 26 | $929 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 11 | $820 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 41 | $787 |
| Timolol Maleate | 48 | $449 |
| Ofloxacin | 37 | $368 |
| Dorzolamide Hcl | 16 | $329 |
| Latanoprost | 16 | $110 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 12 | $108 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Brentwood
- Kevin BlinderBrentwood$333K
- Sabin DangBrentwood$174K
- Alia DurraniBrentwood$53K
- Barton BlackorbyBrentwood$31K
- Ollya FromalBrentwood$14K
- Nicholas IafeBrentwood$9K
- Dillan PatelBrentwood$5K
- Bradley SmithBrentwood$5K
- William AndersonBrentwood$4K
- Prithvi BomdicaBrentwood$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.